During the past decade, Centre for Vaccinology (CEVAC) conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre for Vaccinology (CEVAC)" #1 sponsor was "Janssen Vaccines & Prevention B.V." with 3 trials, followed by "Osivax" with 3 trials sponsored, "University Hospital, Ghent" with 2 trials sponsored, "OSE Immunotherapeutics" with 1 trials sponsored and "Virometix" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre for Vaccinology (CEVAC)" #1 collaborator was "GlaxoSmithKline" with 2 trials as a collaborator, "Innovative Medicines Initiative" with 2 trials as a collaborator, "Max Planck Institute for Infection Biology" with 2 trials as a collaborator, "Novartis Vaccines" with 2 trials as a collaborator and "University of Surrey" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Centre for Vaccinology (CEVAC)" are "Influenza" (3 trials), "Acute Bronchiolitis Due to Respiratory Syncytial Virus" (1 trials), "Coronavirus Disease (COVID-19)" (1 trials), "Covid-19 Prevention" (1 trials) and "Healthy" (1 trials). Many other conditions were trialed in "Centre for Vaccinology (CEVAC)" in a lesser frequency.

Most popular intervention types in "Centre for Vaccinology (CEVAC)" are "Biological" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ad26.COV2.S" (2 trials), "Placebo" (2 trials), "Blood samples" (1 trials), "Boostrix" (1 trials) and "CoVepiT (OSE13E)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre for Vaccinology (CEVAC)" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Centre for Vaccinology (CEVAC)". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Centre for Vaccinology (CEVAC), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centre for Vaccinology (CEVAC), 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".